Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.
Saved in:
| Title: | Efficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma. |
|---|---|
| Authors: | Hennemann A; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France., Collonge Rame MA; Genetic Department, University Hospital, Besancon, France., Puzenat E; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France., Ged C; Univ. Bordeaux, INSERM, BMGIC, Bordeaux, France., Harbon S; Saint Vincent Clinic, Besançon, France., Aubin F; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France., Nardin C; Dermatology Department and Inserm Unit 1098, Franche Comté University and University Hospital, Besancon, France. |
| Source: | Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Sep; Vol. 61 (9), pp. 1140-1142. Date of Electronic Publication: 2022 Aug 11. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1651-226X |
|---|---|
| DOI: | 10.1080/0284186X.2022.2109425 |
